LINC01478

Across TCGA pan-cancer cohorts, LINC01478 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01478 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC01478 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01478 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCS show a favorable association.

READ, MESO, and KIRP are the cancer types where LINC01478 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.532	0.930	<.001	108	view →
MESO	DFS	Tertile	II,III,IV	0.189	0.440	.001	72	view →
KIRP	DFS	Tertile	II,III,IV	0.438	0.801	.001	51	view →
SKCM	DFS	Tertile	II,III,IV	0.392	0.184	.003	48	view →
STAD	DFS	Quartile	IV	0.083	0.400	.002	48	view →
CHOL	DFS	Tertile	All	0.045	0.497	.029	36	view →
LIHC	OS	Tertile	III,IV	0.179	0.660	<.001	36	view →
KICH	DFS	Tertile	All	0.610	0.968	.010	21	view →
UCS	DFS	Tertile	IV	0.996	0.570	.039	18	view →
ESCA	OS	Tertile	III,IV	0.819	0.342	.007	18	view →
LGG	DFS	Tertile	All	0.938	0.794	.003	15	view →
TGCT	DFS	Tertile	All	0.913	0.729	.016	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01478–READ (OS)

Open the READ breakdown →